THW · NYSE · Closed-end fund
abrdn World Healthcare Fund (THW) Price, Holdings & Fees
abrdn World Healthcare Fund (THW) closed at $1,534.26 on Oct 9, 2026, down 0.35% from the previous close of $1,539.67.
Share price, past year
1Y +44.97%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,534.26 |
| Sep 30, 2026 | $1,533.09 |
| Aug 31, 2026 | $1,583.35 |
| Jul 31, 2026 | $1,519.92 |
| Jun 30, 2026 | $1,403.41 |
| May 29, 2026 | $1,370.63 |
| Apr 30, 2026 | $1,315.60 |
| Mar 31, 2026 | $1,289.65 |
| Feb 27, 2026 | $1,176.15 |
| Jan 30, 2026 | $1,150.72 |
| Dec 31, 2025 | $1,147.19 |
| Nov 28, 2025 | $1,166.34 |
| Oct 31, 2025 | $1,087.91 |
Key statistics
- Expense ratio
- 3.00%
- as of May 15, 2026
- Net assets
- $566.5M
- as of Jun 30, 2026
- Holdings
- 137
- as of Jun 30, 2026
- 52-week range
- $1,058.36 – $1,607.19
abrdn World Healthcare Fund's expense ratio is 3.00%: $300.00 a year on $10,000 invested.
Holdings
abrdn World Healthcare Fund held 137 investments worth $566.50M as of Jun 30, 2026. Its largest holding was uniQure NV, at 6.44% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | uniQure NV | 6.44% | $36.51M |
| 2 | AstraZeneca PLC | 4.86% | $27.55M |
| 3 | VeraDermics Inc | 4.20% | $23.79M |
| 4 | Abivax SA | 3.99% | $22.59M |
| 5 | Sanofi SA | 3.55% | $20.10M |
| 6 | VERADERMICS, INC. | 3.22% | $18.24M |
| 7 | Argenx SE | 3.16% | $17.87M |
| 8 | Novo Nordisk A/S | 3.11% | $17.63M |
| 9 | Abbott Laboratories | 2.92% | $16.54M |
| 10 | UnitedHealth Group Inc | 2.80% | $15.85M |
| 11 | Medtronic PLC | 2.63% | $14.92M |
| 12 | Roche Holding AG | 2.53% | $14.35M |
| 13 | Danaher Corp | 2.52% | $14.26M |
| 14 | Thermo Fisher Scientific Inc | 2.50% | $14.17M |
| 15 | Newamsterdam Pharma Co NV | 2.29% | $12.95M |
| 16 | OXB | 2.16% | $12.24M |
| 17 | Intuitive Surgical Inc | 2.15% | $12.20M |
| 18 | Merck & Co Inc | 2.13% | $12.07M |
| 19 | ProQR Therapeutics NV | 2.07% | $11.73M |
| 20 | Boston Scientific Corp | 2.04% | $11.54M |
| 21 | Praxis Precision Medicines Inc | 1.94% | $10.99M |
| 22 | Ventas Inc | 1.79% | $10.12M |
| 23 | Lonza Group AG | 1.67% | $9.48M |
| 24 | Structure Therapeutics Inc | 1.67% | $9.47M |
| 25 | Welltower Inc | 1.61% | $9.14M |
Top 25 of 137 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Stocks | 102.20% |
| Bonds and other debt | 8.48% |
| Preferred stock | 6.52% |
| Derivatives | 3.49% |
| Cash and short-term investments | 0.85% |
| Currency derivatives | 0.10% |
| Country | % of fund |
|---|---|
| United States | 65.60% |
| Netherlands | 14.79% |
| France | 9.38% |
| United Kingdom | 8.87% |
| Switzerland | 7.76% |
| Ireland | 4.41% |
| Cayman Islands | 3.92% |
| Denmark | 3.49% |
| Germany | 1.19% |
| Belgium | 0.72% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the 3 months to Jun 30, 2026, abrdn World Healthcare Fund's total return was +17.97%, as reported to the SEC.
| Month | Total return |
|---|---|
| Jun 30, 2026 | +4.85% |
| May 31, 2026 | +2.02% |
| Apr 30, 2026 | +10.29% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- abrdn World Healthcare Fund
- Ticker
- THW
- Exchange
- NYSE
- Fund type
- Closed-end fund
- SEC CIK
- 0001635977
- Fractional shares
- Yes
Recent SEC filings
- Aug 28, 2026
- Jun 8, 2026
- Dec 8, 2025
- Dec 5, 2025
- Jun 9, 2025
- Dec 9, 2024
- Jun 10, 2024
- Dec 11, 2023
Frequently asked questions
What is THW's price?
abrdn World Healthcare Fund (THW) closed at $1,534.26 on Oct 9, 2026, down 0.35% from the previous close of $1,539.67.
What is THW's expense ratio?
abrdn World Healthcare Fund's expense ratio is 3.00%: $300.00 a year on $10,000 invested.
What does THW hold?
abrdn World Healthcare Fund held 137 investments worth $566.50M as of Jun 30, 2026. Its largest holding was uniQure NV, at 6.44% of the fund. Its five largest holdings were uniQure NV, AstraZeneca PLC, VeraDermics Inc, Abivax SA, Sanofi SA.
How has THW performed?
Over the 3 months to Jun 30, 2026, abrdn World Healthcare Fund's total return was +17.97%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 28, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of May 15, 2026. Prices are generated sample data for development. Data sources and disclosures